|
Name |
Ent-Spathulenol
|
Molecular Formula | C15H24O | |
IUPAC Name* |
(1aS,4aS,7R,7aS,7bS)-1,1,7-trimethyl-4-methylidene-1a,2,3,4a,5,6,7a,7b-octahydrocyclopropa[h]azulen-7-ol
|
|
SMILES |
C[C@]1(CC[C@H]2[C@H]1[C@@H]3[C@@H](C3(C)C)CCC2=C)O
|
|
InChI |
InChI=1S/C15H24O/c1-9-5-6-11-13(14(11,2)3)12-10(9)7-8-15(12,4)16/h10-13,16H,1,5-8H2,2-4H3/t10-,11+,12+,13+,15-/m1/s1
|
|
InChIKey |
FRMCCTDTYSRUBE-HYFYGGESSA-N
|
|
Synonyms |
Ent-Spathulenol; (-)-Spathulenol; Spathulenol, (-)-; (-)-Ent-spathulenol; 77171-55-2; TZZ5I978VX; CHEBI:67836; .beta.-Spathulenol; 1H-Cycloprop(E)azulen-7-ol, decahydro-1,1,7-trimethyl-4-methylene-, (1as,4as,7R,7as,7bs)-; Spathulenol; (1aS,4aS,7R,7aS,7bS)-1,1,7-trimethyl-4-methylidene-1a,2,3,4a,5,6,7a,7b-octahydrocyclopropa[h]azulen-7-ol; UNII-TZZ5I978VX; CHEMBL1774433; DTXSID40227931; 1H-Cycloprop(E)azulen-7-ol, decahydro-1,1,7-trimethyl-4-methylene-, (1as-(1aalpha,4aalpha,7beta,7abeta,7balpha))-; Q27136312; 1H-CYCLOPROP(E)AZULEN-7-OL, DECAHYDRO-1,1,7-TRIMETHYL-4-METHYLENE-, (1AS-(1A.ALPHA.,4A.ALPHA.,7.BETA.,7A.BETA.,7B.ALPHA.))-
|
|
CAS | 77171-55-2 | |
PubChem CID | 13854255 | |
ChEMBL ID | CHEMBL1774433 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 220.35 | ALogp: | 3.1 |
HBD: | 1 | HBA: | 1 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 20.2 | Aromatic Rings: | 3 |
Heavy Atoms: | 16 | QED Weighted: | 0.608 |
Caco-2 Permeability: | -4.384 | MDCK Permeability: | 0.00001930 |
Pgp-inhibitor: | 0.003 | Pgp-substrate: | 0.002 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.913 |
30% Bioavailability (F30%): | 0.008 |
Blood-Brain-Barrier Penetration (BBB): | 0.896 | Plasma Protein Binding (PPB): | 58.49% |
Volume Distribution (VD): | 1.055 | Fu: | 37.94% |
CYP1A2-inhibitor: | 0.386 | CYP1A2-substrate: | 0.404 |
CYP2C19-inhibitor: | 0.144 | CYP2C19-substrate: | 0.804 |
CYP2C9-inhibitor: | 0.139 | CYP2C9-substrate: | 0.243 |
CYP2D6-inhibitor: | 0.016 | CYP2D6-substrate: | 0.443 |
CYP3A4-inhibitor: | 0.042 | CYP3A4-substrate: | 0.315 |
Clearance (CL): | 11.055 | Half-life (T1/2): | 0.139 |
hERG Blockers: | 0.059 | Human Hepatotoxicity (H-HT): | 0.312 |
Drug-inuced Liver Injury (DILI): | 0.292 | AMES Toxicity: | 0.008 |
Rat Oral Acute Toxicity: | 0.908 | Maximum Recommended Daily Dose: | 0.1 |
Skin Sensitization: | 0.455 | Carcinogencity: | 0.645 |
Eye Corrosion: | 0.814 | Eye Irritation: | 0.583 |
Respiratory Toxicity: | 0.977 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003084 | 0.556 | D0L2LS | 0.286 | ||||
ENC002222 | 0.483 | D0U3GL | 0.284 | ||||
ENC001469 | 0.450 | D0Z1XD | 0.284 | ||||
ENC002543 | 0.448 | D04VIS | 0.276 | ||||
ENC003088 | 0.433 | D0K0EK | 0.275 | ||||
ENC001196 | 0.426 | D0W3OS | 0.274 | ||||
ENC003085 | 0.411 | D0SC8F | 0.272 | ||||
ENC002553 | 0.400 | D06CGB | 0.271 | ||||
ENC001814 | 0.385 | D0D2VS | 0.268 | ||||
ENC002110 | 0.377 | D0Q6NZ | 0.267 |